Emergent BioSolutions (EBS) Shares Outstanding (2010 - 2026)

Emergent BioSolutions has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $51.3 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 4.47% year-over-year to $51.3 million in Q2 2026; TTM through Jun 2026 was $51.3 million, a 4.47% decrease from a year earlier, with the FY2025 full-year figure at $52.1 million, down 4.05% from the prior year.
• Shares Outstanding (Entity) was $51.3 million for Q2 2026 at Emergent BioSolutions, down from $51.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $54.5 million in Q1 2025, with the low at $49.9 million in Q2 2022.
• Average Shares Outstanding (Entity) over 5 years is $52.0 million, with a median of $52.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) dropped 7.08% in 2022, then grew 4.44% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $50.1 million in 2022, then increased by 4.19% to $52.2 million in 2023, then advanced by 4.02% to $54.3 million in 2024, then slipped by 4.05% to $52.1 million in 2025, then retreated by 1.54% to $51.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $51.3 million (Q2 2026), $51.8 million (Q1 2026), and $52.1 million (Q4 2025), per Business Quant data.